Market Newsdesk

April 22, 2026 4:46 pm

Hexcel Reports 2026 First Quarter Results

Hexcel Reports 2026 First Quarter Results

STAMFORD, Conn.–(BUSINESS WIRE)–
Hexcel Corporation (NYSE: HXL):

Q1 2026 GAAP diluted EPS of $0.49 compared to Q1 2025 GAAP diluted EPS of $0.35.
Q1 2026 adjusted diluted EPS of $0.59 compared to Q1 2025 adjusted diluted EPS of $0.37
Q1 2026 Sales were $502 million, an increase of 9.9% compared to Q1 2025 sales of $457 million.
Refinanced the $750 million syndicated Revolver and extended maturity to 2031
2026 guidance unchanged

See Table C for reconciliation of GAAP and non-GAAP operating income, net income, earnings per share and operating cash flow to free cash flow. Free cash flow is cash from operations less capital expenditures.

Summary of Results from Operations
	Quarters Ended
	March 31,
(In millions, except per share data)	2026			2025			% Change

Net Sales	$	501.5		$	456.5			9.9	%
Net sales change in constant currency								8.8	%
Operating Income		57.6			44.2			30.3	%
Net Income		37.2			28.9			28.7	%
Diluted net income per common share	$	0.49		$	0.35			40.0	%

Non-GAAP measures for year-over-year comparison (Table C)
Adjusted Operating Income	$	67.5		$	45.3			49.0	%
As a % of sales		*13.5*	%		9.9	%
Adjusted Net Income		45.5			30.1			51.2	%
Adjusted diluted net income per share	$	0.59		$	0.37			59.5	%

Hexcel Corporation (NYSE: HXL) today reported first quarter 2026 results including net sales of $502 million and adjusted diluted EPS of $0.59 per share.

Chairman, CEO and President Tom Gentile said, “The Hexcel team delivered strong first quarter results on rising commercial aerospace build rates supported by the normalization of channel inventory. Our first quarter sales increased ten percent and earnings per share grew at a significantly higher rate, underscoring the benefit from significant operating leverage as we grow back into existing capacity. Our priorities remain centered on execution and operational discipline as we support the rate ramps of our customers.”

Mr. Gentile continued, “We remain confident in our growth outlook and we are reaffirming our full year 2026 guidance despite geopolitical uncertainty in the Middle East and lingering commercial aerospace supply chain challenges. We continue to actively monitor the markets and remain in close contact with our suppliers and customers. At present, we believe we are well positioned to mitigate a substantial portion of the near-term impact of higher oil and energy prices to our cost base. Higher oil prices in the short-term places an even greater emphasis on fuel efficiency in the aerospace industry, which further reinforces the value proposition of lightweight advanced composite material.”

Markets

Sales in the first quarter of 2026 were $501.5 million compared to $456.5 million in the first quarter of 2025.

Commercial Aerospace (66% of YTD Sales)

Commercial Aerospace sales of $332.7 million increased 18.8% (19.0% in constant currency) for the first quarter of 2026 compared to the first quarter of 2025. Sales increased for each of the four major programs, including the Airbus A350 and A320 and the Boeing 787 and 737 MAX. Other Commercial Aerospace sales increased 15.6% for the first quarter of 2026 compared to the first quarter of 2025 with sales increasing for both regional jets and business jets.

Defense, Space & Other (34% of YTD Sales)

Defense, Space & Other sales of $168.8 million decreased 4.3% (6.9% in constant currency) for the quarter as compared to the first quarter of 2025. The sales decrease reflected the September 30, 2025 divestment of the Austrian-based industrial business. Within Defense & Space, first quarter 2026 sales increased for European fighter aircraft and military helicopters, including both US and European programs. Space sales were lower year-over-year on softer launchers and rocket motors.

Consolidated Operations

Gross margin for the first quarter of 2026 was 26.9% compared to 22.4% in the prior year, benefiting from higher sales leverage. As a percentage of sales, selling, general and administrative expenses for the first quarter of 2026 were 9.9% compared to 9.5% for the first quarter of 2025. R&D expenses as a percentage of sales for the first quarter of 2026 were 3.5% compared to 3.0% for the first quarter of 2025. Adjusted operating income in the first quarter of 2026 was $67.5 million or 13.5% of sales, compared to $45.3 million or 9.9% of sales in 2025. The impact of exchange rates on operating income as a percentage of sales was unfavorable by approximately 80 basis points in the first quarter of 2026 compared to the first quarter of 2025. Other operating expense for the first quarter of 2026 included restructuring expenses related to the expected shutdown of industrial-oriented manufacturing at the Leicester, UK facility and non-recurring professional fees.

Cash and other

Net cash provided by operating activities in the first quarter of 2026 was $19.0 million, compared to a use of $28.5 million for the first quarter of 2025. Working capital was a cash use of $63.1 million in the first quarter of 2026 compared to a use of $97.7 million in the first quarter of 2025. Capital expenditures on a cash basis were $25.2 million for the first quarter of 2026 compared to $26.1 million for the first quarter of 2025. Free cash flow was ($6.2) million in the first quarter of 2026 compared to ($54.6) million in the first quarter of 2025. Free cash flow is defined as cash generated from operating activities less cash paid for capital expenditures. Capital expenditures on an accrual basis were $17.7 million for the first quarter of 2026 compared to $17.1 million for the first quarter of 2025.
On March 31, 2026, the Company entered into a $750 million senior unsecured revolving credit facility maturing in 2031, refinancing and terminating its prior $750 million revolving facility that was scheduled to mature in 2028.
The Company did not repurchase any shares of its common stock during the first quarter of 2026. The remaining authorization under the Company’s share repurchase program was $380.6 million as of March 31, 2026.
As announced today, the Board of Directors declared a quarterly dividend of $0.18 per share payable to stockholders of record as of May 4, 2026, with a payment date of May 11, 2026.

2026 Guidance – Unchanged

Sales of $2.0 billion to $2.1 billion
Adjusted diluted earnings per share of $2.10 to $2.30
Free cash flow of greater than $195 million
Capital expenditures less than $100 million

Hexcel will host a conference call at 9:30 a.m. ET, on April 23, 2026 to discuss first quarter 2026 results. The live webcast will be available on the Investor Relations section of the Hexcel website via the following link: https://events.q4inc.com/attendee/224695473. The event can also be accessed by dialing +1 (646) 307-1963. The conference ID is 2360739. Replays of the call will be available on the website.

About Hexcel

Hexcel Corporation is a global leader in advanced lightweight composites technology. We provide innovative, high-performance material solutions that are lighter, stronger and tougher, shaping a world that moves farther, smarter and more efficiently. Our broad and unrivaled product range includes carbon fiber, specialty reinforcements, prepregs and other fiber-reinforced matrix materials, honeycomb, resins, engineered core, and composite structures for use in commercial aerospace, defense and space, and industrial applications.

Disclaimer on Forward Looking Statements

This news release contains statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to the estimates and expectations based on aircraft production rates provided by Airbus, Boeing and others, and the revenues we may generate from an aircraft model or program; expectations with regard to the impact of regulatory activity related to the Boeing 737 MAX on our revenues; expectations with regard to raw material cost and availability, including any impact associated with quotas, duties, tariffs, taxes or other similar restrictions upon the import or export of materials or the Middle East conflict; expectations of composite content on new commercial aircraft programs and our share of those requirements; expectations regarding revenues from defense and space applications, including whether certain programs might be curtailed or discontinued, and government funding opportunities; expectations regarding sales for industrial applications; expectations regarding cash generation, working capital trends, and inventory levels; expectations as to the level of research and development investment, capital expenditures, capacity, including the timing of completion of capacity expansions, and qualification of new products; expectations regarding our ability to improve or maintain margins; expectations regarding our ability to attract, motivate, and retain the workforce necessary to execute our business strategy; projections regarding our tax rate; expectations with regard to the continued impact of macroeconomic factors or geopolitical issues or conflicts, including the Middle East conflict; expectations regarding our strategic initiatives, including our sustainability goals or restructuring or alignment activities; expectations with regard to the effectiveness of cybersecurity measures; expectations regarding the outcome of legal matters or the impact of changes in laws or regulations; expectations relating to our share repurchase program and dividends; and our expectations of financial results for 2026 and beyond. Actual results may differ materially from the results anticipated in the forward-looking statements due to a variety of factors, including but not limited to uncertainty regarding the amount and timing of future share repurchases and the source of funds used for such repurchases; the extent of the impact of macroeconomic factors or geopolitical issues or conflicts, including U.S. trade policy and retaliatory actions taken in response and the Middle East conflict; reductions in sales to any significant customers, particularly Airbus or Boeing, including related to regulatory activity or public scrutiny impacting the Boeing 737 MAX; our ability to effectively adjust production and inventory levels to align with customer demand; our ability to effectively motivate, retain and hire the necessary workforce; the availability and cost of raw materials, including the impact of supply disruptions, inflation, tariffs and the Middle East conflict; our ability to successfully implement or realize our strategic initiatives, including our sustainability goals or any restructuring or alignment activities in which we may engage; changes in sales mix; changes in current pricing due to cost levels; changes in aerospace build or delivery rates; any impact from a prolonged shutdown of the U.S. federal government; changes in government defense procurement or investment budgets; timely new product development or introduction; our ability to install, staff and qualify necessary capacity or complete capacity expansions to meet customer demand; our ability to execute future share repurchases or dividends and the source of funds used for such repurchases or dividends; cybersecurity-related risks, including the potential impact of breaches or intrusions; currency exchange rate fluctuations; uncertainty related to governmental actions and changes in political, social and economic conditions, including the effect of change in global trade policies, tariff rates, economic sanctions and embargoes; work stoppages or other labor disruptions; our ability to successfully complete any strategic acquisitions, investments or dispositions; compliance with environmental, health, safety and other related laws and regulations, including those related to climate change; the effects of natural disasters or other severe weather events, which may be worsened by the impact of climate change, and other severe catastrophic events, including any public health crisis; and the unexpected outcome of legal matters or impact of changes in laws or regulations. Additional risk factors are described in our filings with the Securities and Exchange Commission. We do not undertake an obligation to update our forward-looking statements to reflect future events.

Hexcel Corporation and Subsidiaries
Condensed Consolidated Statements of Operations
	Unaudited
	Quarters Ended
	March 31,
(In millions, except per share data)	2026			2025
Net sales	$	501.5		$	456.5
Cost of sales		366.8			354.1
Gross margin		134.7			102.4
% Gross Margin		*26.9*	%		22.4	%

Selling, general and administrative expenses		49.4			43.3
Research and development expenses		17.8			13.8
Other operating expense		9.9			1.1
Operating income		57.6			44.2
Interest expense, net		11.8			7.8
Other expense		0.3			0.4
Income before income taxes		45.5			36.0
Income tax expense		8.3			7.1
Net income	$	37.2		$	28.9


Basic net income per common share:	$	0.49		$	0.36

Diluted net income per common share:	$	0.49		$	0.35

Weighted-average common shares:
Basic		75.9			81.1
Diluted		76.7			81.7

Hexcel Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
	Unaudited
	March 31,			December 31,
(In millions)	2026			2025
Assets
Cash and cash equivalents	$	54.1		$	71.0
Accounts receivable, net		291.0			249.3
Inventories, net		339.8			328.8
Contract assets		40.4			35.9
Prepaid expenses and other current assets		44.4			45.7
Total current assets		769.7			730.7

Property, plant and equipment		3,311.7			3,322.4
Less accumulated depreciation		(1,718.9	)		(1,710.9	)
Net property, plant and equipment		1,592.8			1,611.5

Goodwill and other intangible assets, net		237.4			239.8
Investments in affiliated companies		5.0			5.0
Other assets		119.0			117.0
Total assets	$	2,723.9		$	2,704.0

Liabilities and Stockholders’ Equity
Liabilities:
Accounts payable	$	140.7		$	146.6
Accrued compensation and benefits		67.2			79.0
Accrued liabilities		105.8			97.1
Total current liabilities		313.7			322.7

Long-term debt		998.1			993.0
Retirement obligations		27.8			28.4
Other non-current liabilities		118.1			109.2
Total liabilities	$	1,457.7		$	1,453.3

Stockholders’ equity:
Common stock, $0.01 par value, 200.0 shares authorized, 112.5 shares issued at March 31, 2026 and 112.1 shares issued at December 31, 2025	$	1.1		$	1.1
Additional paid-in capital		992.5			994.9
Retained earnings		2,330.5			2,307.0
Accumulated other comprehensive loss		(30.5	)		(12.9	)
		3,293.6			3,290.1

Less – Treasury stock, at cost, 37.1 shares at March 31, 2026 and 36.4 shares at December 31, 2025		(2,027.4	)		(2,039.4	)
Total stockholders’ equity		1,266.2			1,250.7
Total liabilities and stockholders’ equity	$	2,723.9		$	2,704.0

Hexcel Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows
	Unaudited
	Quarters Ended
	March 31,
(In millions)	2026			2025

Cash flows from operating activities
Net income	$	37.2		$	28.9
Reconciliation to net cash used for operating activities:
Depreciation and amortization		30.4			29.8
Amortization related to financing		0.4			–
Deferred income taxes		3.5			2.7
Stock-based compensation		9.3			9.7
Restructuring expenses, net of payments		3.6			(0.3	)
Debt extinguishment costs		–			0.4
Loss on divestiture of assets		–			1.1

Changes in assets and liabilities:
Increase in accounts receivable		(43.0	)		(42.5	)
Increase in inventories		(14.3	)		(16.8	)
Increase in prepaid expenses and other current assets		(6.6	)		(5.7	)
Decrease (increase) in accounts payable/accrued liabilities		0.8			(32.7	)
Other – net		(2.3	)		(3.1	)
Net cash provided by (used for) operating activities (a)		19.0			(28.5	)

Cash flows from investing activities
Capital expenditures (b)		(25.2	)		(26.1	)
Payments on divestiture of assets		–			(1.1	)
Net cash used for investing activities		(25.2	)		(27.2	)

Cash flows from financing activities
Borrowings, net from senior unsecured credit facilities		5.0			90.0
Redemption of 4.7% senior notes due 2025		–			(300.0	)
Proceeds from issuance of 5.875% senior notes due 2035		–			300.0
Repurchases of common stock		–			(50.4	)
Issuance costs related to senior unsecured credit facilities		(1.9	)		–
Repayment of finance lease obligation and other debt, net		–			(4.2	)
Dividends paid		(13.7	)		(13.8	)
Activity under stock plans		0.3			(3.4	)
Net cash (used for) provided by financing activities		(10.3	)		18.2
Effect of exchange rate changes on cash and cash equivalents		(0.4	)		1.3
Net decrease in cash and cash equivalents		(16.9	)		(36.2	)
Cash and cash equivalents at beginning of period		71.0			125.4
Cash and cash equivalents at end of period	$	54.1		$	89.2

Supplemental data:
Free Cash Flow (a)+(b)	$	(6.2	)	$	(54.6	)
Accrual basis additions to property, plant and equipment	$	17.7		$	17.1

Hexcel Corporation and Subsidiaries
Net Sales to Third-Party Customers by Market
Quarters Ended March 31, 2026 and 2025								Unaudited					Table A
(In millions)	As Reported							Constant Currency (a)
					B/(W)			FX					B/(W)
Market	2026		2025		%			Effect (b)			2025		%
Commercial Aerospace	$	332.7	$	280.1		18.8		$	(0.6	)	$	279.5		19.0
Defense, Space & Other		168.8		176.4		(4.3	)		4.9			181.3		(6.9	)
Consolidated Total	$	501.5	$	456.5		9.9		$	4.3		$	460.8		8.8

Consolidated % of Net Sales	%		%								%
Commercial Aerospace		66.3		61.4								60.7
Defense, Space & Other		33.7		38.6								39.3
Consolidated Total		100.0		100.0								100.0

(a)		To assist in the analysis of the Company’s net sales trend, total net sales and sales by market for the quarter ended March 31, 2025 have been estimated using the same U.S. dollar, British pound and Euro exchange rates as applied for the respective period in 2026 and are referred to as “constant currency” sales.
(b)		FX effect is the estimated impact on “as reported” net sales due to changes in foreign currency exchange rates.

Hexcel Corporation and Subsidiaries

Segment Information

Unaudited

Table B

(In millions)

Composite Materials

Engineered Products

Corporate

& Other (a)

Total

First Quarter 2026

Net sales to external customers

398.8

102.7

–

501.5

Intersegment sales

28.4

1.6

(30.0

)

–

Total sales

427.2

104.3

(30.0

)

501.5

Other operating expense

5.7

–

4.2

9.9

Operating income (loss)

69.7

15.2

(27.3

)

57.6

% Operating margin

16.3

14.6

11.5

Depreciation and amortization

27.2

3.2

–

30.4

Stock-based compensation expense

3.4

0.8

5.1

9.3

Accrual based additions to capital expenditures

16.0

1.7

–

17.7

First Quarter 2025

Net sales to external customers

365.3

91.2

–

456.5

Intersegment sales

20.1

0.3

(20.4

)

–

Total sales

385.4

91.5

(20.4

)

456.5

Other operating expense

–

1.1

–

1.1

Operating income (loss)

54.6

5.1

(15.5

)

44.2

% Operating margin

14.2

5.6

9.7

Depreciation and amortization

26.6

3.2

–

29.8

Stock-based compensation expense

3.0

0.8

5.9

9.7

Accrual based additions to capital expenditures

15.5

1.6

–

17.1

(a)

Hexcel does not allocate corporate expenses to the operating segments.

Hexcel Corporation and Subsidiaries
Reconciliation of GAAP to Non-GAAP Operating Income, Net Income, EPS and Operating Cash Flow to Free Cash Flow					Table C
	Unaudited
	Quarters Ended
	March 31,
(In millions)	2026		2025
GAAP operating income	$	57.6	$	44.2
Other operating expense (a)		9.9		1.1
Adjusted operating income (Non-GAAP)	$	67.5	$	45.3

	Unaudited
	Quarters Ended March 31,
	2026				2025
(In millions, except per diluted share data)	Net Income		EPS		Net Income		EPS
GAAP	$	37.2	$	0.49	$	28.9	$	0.35
Other operating expense, net of tax (a)		8.1		0.10		0.9		0.01
Other expense, net of tax (b)		0.2		–		0.3		0.01
Non-GAAP	$	45.5	$	0.59	$	30.1	$	0.37

	Unaudited
	Quarters Ended March 31,
(In millions)	2026			2025
Net cash used for operating activities	$	19.0		$	(28.5	)
Less: Capital expenditures		(25.2	)		(26.1	)
Free cash flow (Non-GAAP)	$	(6.2	)	$	(54.6	)

(a)		The quarter ended March 31, 2026 included $5.5 million of restructuring expenses related to the expected shutdown of industrial manufacturing at the Leicester, UK facility and $4.1 million for non-recurring professional fees. The quarter ended March 31, 2025 included a loss of $1.1 million for the divestiture of the Hartford, Connecticut business.
(b)		The quarter ended March 31, 2026 included costs associated with the new credit facility. The quarter ended March 31, 2025 included debt extinguishment costs.
NOTE: Management believes that adjusted operating income, adjusted net income, adjusted diluted net income per share and free cash flow, which are non-GAAP measures, are meaningful to investors because they provide a view of Hexcel with respect to the underlying operating results excluding special items. Special items represent significant charges or credits that are important to an understanding of Hexcel’s overall operating results in the periods presented. Non-GAAP measurements are not recognized in accordance with generally accepted accounting principles and should not be viewed as an alternative to GAAP measures of performance.

Hexcel Corporation and Subsidiaries
Schedule of Total Debt, Net of Cash							Table D
	Unaudited
	March 31,			December 31,			December 31,
(In millions)	2026			2025			2024

Current portion finance lease	$	–		$	–		$	0.1
Total current debt		–			–			0.1

Senior unsecured credit facility		300.0			295.0			–
4.7% senior notes due 2025		–			–			300.0
3.95% senior notes due 2027		400.0			400.0			400.0
5.875% senior notes due 2035		300.0			300.0			–
Senior notes original issue discounts		(0.2	)		–			(0.4	)
Senior notes deferred financing costs		(3.7	)		(4.2	)		(0.9	)
Other debt		2.0			2.2			1.9
Total long-term debt		998.1			993.0			700.6
Total Debt		998.1			993.0			700.7
Less: Cash and cash equivalents		(54.1	)		(71.0	)		(125.4	)
Total debt, net of cash	$	944.0		$	922.0		$	575.3

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422181577/en/

Kurt Goddard | Vice President Investor Relations | [email protected] | +1 (203)-352-6826

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Defense Other Defense Hardware Engineering Chemicals/Plastics Technology Aerospace Manufacturing

MEDIA:

Logo

April 22, 2026 4:45 pm

U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates

U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates

HOUSTON–(BUSINESS WIRE)–
U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 7, 2026.

Conference Call	Date:	Thursday, May 7, 2026
	Time:	10:30 am Eastern / 9:30 am Central
	Dial-In Number	(800) 445-7795 Primary or
		(785) 424-1699 Alternate
	Conference ID:	USPHQ126
(In order to join this conference call,
You will be required to provide the Conference ID listed above)
The participate, please call in 15 minutes prior to start time

To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until August 5, 2026 at USPH’s website.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 783 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422582300/en/

U.S. Physical Therapy, Inc.

Jason Curtis, Interim Chief Financial Officer

Email: [email protected]

Chris Reading, Chief Executive Officer

(713) 297-7000

Three Part Advisors

Joe Noyons

(817) 778-8424

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Physical Therapy Health

MEDIA:

Logo

April 22, 2026 4:43 pm

Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026

ROCKVILLE, Md., April 22, 2026 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it will report first quarter 2026 financial and business results after the market closes on Tuesday, May 5, 2026.

Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call and webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to discuss these results. Following management’s prepared remarks and discussion of business results, the call will be open for questions.

A live webcast will be accessible in the Events & Presentations section of the Company’s Investor Relations website at www.supernus.com/Investors.

Participants may also pre-register any time before the call here. Once registration is completed, participants will be provided a dial-in number with a personalized conference code to access the call. Please dial in 15 minutes prior to the start time.

Following the live call, a replay will be available on the Company’s Investor Relations website at www.supernus.com/Investors. The webcast will be available on the Company’s website for 60 days following the live call.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Our diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. We are developing a broad range of novel product candidates for CNS disorders.

For more information, please visit www.supernus.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements do not convey historical information but relate to predicted or potential future events that are based upon management’s current expectations. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In addition to the factors mentioned in this press release, such risks and uncertainties include, but are not limited to, the Company’s ability to sustain and increase its profitability; the Company’s ability to raise sufficient capital to fully implement its corporate strategy; the implementation of the Company’s corporate strategy; the Company’s future financial performance and projected expenditures; the Company’s ability to increase the number of prescriptions written for each of its products, and the products of its subsidiaries; the Company’s ability to increase its net revenue from its products, and the products of its subsidiaries; the Company’s ability to commercialize its products, and the products of its subsidiaries the Company’s ability to enter into future collaborations with pharmaceutical companies and academic institutions or to obtain funding from government agencies; the Company’s product research and development activities, including the timing and progress of the Company’s clinical trials, and projected expenditures; the Company’s ability to receive, and the timing of any receipt of, regulatory approvals to develop and commercialize the Company’s product candidates; the Company’s ability to protect its intellectual property and the intellectual property of its subsidiaries and operate its business without infringing upon the intellectual property rights of others; the Company’s expectations regarding federal, state and foreign regulatory requirements; the therapeutic benefits, effectiveness and safety of the Company’s product candidates; the accuracy of the Company’s estimates of the size and characteristics of the markets that may be addressed by its product candidates; the Company’s ability to increase its manufacturing capabilities for its products and product candidates; the Company’s projected markets and growth in markets; the Company’s product formulations and patient needs and potential funding sources; the Company’s staffing needs; changes to laws and regulations applicable to our industry, the impact of macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs; and other risk factors set forth from time to time in the Company’s filings with the Securities and Exchange Commission made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

CONTACTS:

Jack A. Khattar, President and CEO
Timothy C. Dec, Senior Vice President and CFO
Supernus Pharmaceuticals, Inc.
(301) 838-2591

INVESTOR CONTACT:

Peter Vozzo
ICR Healthcare
(443) 213-0505
[email protected]

April 22, 2026 4:42 pm

Xylem Announces Participation at Upcoming Investor Conferences

Xylem Announces Participation at Upcoming Investor Conferences

WASHINGTON–(BUSINESS WIRE)–
Xylem Inc. (NYSE: XYL), a leading global water solutions company that empowers customers and communities to build a more water-secure world, announced today that it will participate in the following upcoming conferences:

Oppenheimer 21st Annual Industrial Growth Conference, May 7, Virtual – Management and Investor Relations will present and participate in investor meetings.
Stifel 2026 Boston Cross Sector 1×1 Conference, June 3, Boston – Management and Investor Relations will present and participate in investor meetings.

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422470625/en/

Media

Press Office

+1 (978) 704-5149

[email protected]

Investors

Michael Travers

+1 (724) 772-1597

[email protected]

KEYWORDS: District of Columbia United States North America

INDUSTRY KEYWORDS: Technology Finance Other Energy Utilities Other Technology Professional Services Other Natural Resources Energy Natural Resources Other Professional Services

MEDIA:

Logo

April 22, 2026 4:42 pm

First American Financial Reports First Quarter 2026 Results

First American Financial Reports First Quarter 2026 Results

SANTA ANA, Calif.–(BUSINESS WIRE)–
First American Financial Corporation (NYSE: FAF), a premier provider of title, settlement and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced financial results for the first quarter ended March 31, 2026.

Current Quarter Highlights

Earnings per diluted share of $1.21, or $1.33 per share on an adjusted basis
- Net investment losses of $9 million, or 7 cents per diluted share
- Purchase-related intangible amortization of $7 million, or 5 cents per diluted share
Total revenue of $1.8 billion, up 16 percent compared with last year, on both a GAAP and adjusted basis
Title Insurance and Services segment investment income of $154 million, up 12 percent compared with last year
Title Insurance and Services segment pretax margin of 9.6 percent, or 10.4 percent on an adjusted basis
Commercial revenues of $271 million, up 48 percent compared with last year
Home Warranty segment pretax margin of 23.5 percent, or 23.8 percent on an adjusted basis
Debt-to-capital ratio of 32.2 percent, or 21.9 percent excluding secured financings payable of $1.1 billion
Repurchased 556,336 shares for a total of $33 million at an average price of $60.21
- In the second quarter, through April 22, repurchased 295,872 shares for a total of $18 million at an average price of $61.61
In April, named one of the 100 Best Companies to Work For by Great Place to Work^® and Fortune Magazine for the eleventh consecutive year

Selected Financial Information ($ in millions, except per share data)

	Three Months Ended
	March 31,
	2026		2025
Total revenue	$	1,838.0	$	1,582.3
Income before taxes	$	161.8	$	96.6

Net income	$	125.1	$	74.2
Net income per diluted share	$	1.21	$	0.71

Adjusted net income	$	137.3	$	87.9
Adjusted net income per diluted share	$	1.33	$	0.84

Total revenue for the first quarter of 2026 was $1.8 billion, up 16 percent compared with the first quarter of 2025. Net income in the current quarter was $125 million, or $1.21 per diluted share, compared with net income of $74 million, or 71 cents per diluted share, in the first quarter of 2025. Adjusted net income in the current quarter was $137 million, or $1.33 per diluted share, compared with $88 million, or 84 cents per diluted share, in the first quarter of last year. Net investment losses in the current quarter were $9 million, or 7 cents per diluted share, compared with net investment losses of $11 million, or 8 cents per diluted share, in the first quarter of last year. Purchase-related intangible amortization in both the current and prior year quarters was $7 million, or 5 cents per diluted share. The effective tax rate this quarter was 22.9 percent.

“We delivered a strong first quarter, with adjusted earnings per share up 58 percent compared to the prior year,” said Mark Seaton, chief executive officer at First American Financial Corporation. “Our results were driven by our commercial business, which achieved record first-quarter revenue. In addition, investment income in our title segment grew 12 percent, despite a decline in the federal funds rate, in part due to continued success in capturing additional deposit sources at our bank. Our adjusted pretax title margin was 10.4 percent for the quarter, a great start to the year considering continued softness in the residential market.

“Beyond our financial results, we are committed to deploying AI solutions across the company to amplify the talents of our team, better serve our customers and strengthen our capabilities. Our combination of unique data assets, deep domain expertise, and innovative technology provides us with a competitive advantage as AI adoption accelerates. We are energized by the opportunities ahead and will continue to invest in our people, processes, and products as we work to extend our leadership position in the industry.”

Title Insurance and Services ($ in millions, except average revenue per order)

	Three Months Ended
	March 31,
	2026			2025
Total revenues	$	1,732.3		$	1,484.4

Income before taxes	$	167.0		$	106.8
Pretax margin		9.6	%		7.2	%
Adjusted pretax margin		10.4	%		7.9	%

Title open orders⁽¹⁾		182,900			168,900
Title closed orders⁽¹⁾		119,900			110,300

U.S. Commercial
Total revenues	$	271.2		$	183.8
Open orders		27,500			26,600
Closed orders		15,200			14,000
Average revenue per order	$	17,900		$	13,100
⁽¹⁾ U.S. direct title insurance orders only.

Total revenues for the Title Insurance and Services segment on both a GAAP and adjusted basis were $1.7 billion in the first quarter, up 17 percent compared with the same quarter of 2025. Direct premiums and escrow fees increased by 21 percent compared with the first quarter of last year, driven by a 13 percent increase in the average revenue per order closed and a 9 percent increase in the number of direct title orders closed in our domestic operations. The average revenue per direct title order rose to $4,229, primarily due to an increase in the average revenue per order for commercial transactions, partially offset by a shift in the mix from higher premium purchase transactions to lower premium refinance transactions. Agent premiums, which are recorded on approximately a one-quarter lag relative to direct premiums, were up 16 percent compared with last year.

Information and other revenues were $269 million during the quarter, up $33 million, or 14 percent, compared with last year. The increase was primarily driven by revenue growth in the company’s subservicing business, higher demand for non-insured information products and services, and refinance activity in the company’s Canadian operations.

Investment income was $154 million in the first quarter, up $17 million compared with the same quarter last year. The increase was primarily driven by higher interest income from the company’s investment portfolio and warehouse lending business. Net investment losses were $8 million in the current quarter compared with $4 million in the same quarter last year.

Personnel costs were $546 million in the first quarter, up $62 million, or 13 percent, compared with the same quarter of 2025. The increase in personnel costs was primarily attributable to incentive compensation expense resulting from higher revenue and profitability, and higher salary expense.

Other operating expenses of $277 million in the current quarter were up $31 million, or 13 percent, compared with the first quarter of 2025, primarily due to higher production expense driven by higher volumes and increased software expense.

The provision for policy losses and other claims was $40 million in the first quarter, or 3.0 percent of title premiums and escrow fees, unchanged from the prior year. The first quarter rate reflects an ultimate loss rate of 3.75 percent for the current policy year and a net decrease of $10 million in the loss reserve estimate for prior policy years.

Depreciation and amortization expense was $53 million in the first quarter, up $2 million, or 4 percent, compared with the same period last year.

Interest expense was $27 million in the current quarter, up $7 million, or 34 percent, compared with last year due to higher interest expense in the warehouse lending business and on deposit balances at the company’s bank subsidiary.

The Title Insurance and Services segment posted pretax income of $167 million in the first quarter, compared with pretax income of $107 million in the first quarter of 2025. Pretax margin was 9.6 percent in the current quarter, compared with 7.2 percent last year. Adjusted pretax margin was 10.4 percent in the current period, compared with 7.9 percent last year.

Home Warranty ($ in millions)

	Three Months Ended
	March 31,
	2026			2025
Total revenues	$	109.8		$	107.8

Income before taxes	$	25.8		$	24.7
Pretax margin		23.5	%		22.9	%
Adjusted pretax margin		23.8	%		23.5	%

Total revenues for the Home Warranty segment were $110 million in the first quarter, up 2 percent compared with last year. The segment posted pretax income of $26 million this quarter, up 4 percent compared with last year. The claim loss rate improved to 36 percent in the first quarter, compared with 37 percent last year, due to small reductions in the number and severity of claims. Home Warranty’s pretax margin was 23.5 percent this quarter, compared with 22.9 percent last year. Adjusted pretax margin was 23.8 percent this quarter, compared with 23.5 percent last year.

Corporate

The Corporate segment pretax loss was $31 million in the first quarter, compared with a loss of $35 million last year. Excluding net investment gains and losses, the Corporate pretax loss was $30 million in the current quarter, compared with a $28 million loss in the first quarter of last year.

Teleconference/Webcast

First American’s first quarter 2026 results will be discussed in more detail on Thursday, April 23, 2026, at 11 a.m. EDT, via teleconference. The toll-free dial-in number is +1-877-407-8293. Callers from outside the United States may dial +1-201-689-8349.

The live audio webcast of the call will be available on First American’s website at www.firstam.com/investor. An audio replay of the conference call will be available through May 7, 2026, by dialing +1-201-612-7415 and using the conference ID 13759993. An audio archive of the call will also be available on First American’s investor website.

About First American

First American Financial Corporation (NYSE: FAF) is a premier provider of title, settlement and risk solutions for real estate transactions. With its combination of financial strength and stability built over 135 years, innovative proprietary technologies, and unmatched data assets, the company is leading the digital transformation of its industry. First American also provides data products to the title industry and other third parties; valuation products and services; mortgage subservicing; home warranty products; banking, trust and wealth management services; and other related products and services. With total revenue of $7.5 billion in 2025, the company offers its products and services directly and through its agents throughout the United States and abroad. In 2026, First American was named one of the 100 Best Companies to Work For by Great Place to Work^® and Fortune Magazine for the eleventh consecutive year. More information about the company can be found at www.firstam.com.

Website Disclosure

First American posts information of interest to investors at www.firstam.com/investor. This includes opened and closed title insurance order counts for its U.S. direct title insurance operations, which are posted approximately 10 to 12 days after the end of each month.

Forward-Looking Statements

Certain statements made in this press release and the related management commentary contain, and responses to investor questions may contain, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and may contain the words “believe,” “anticipate,” “expect,” “intend,” “plan,” “predict,” “estimate,” “project,” “will be,” “will continue,” “will likely result,” or other similar words and phrases or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” or “could.” These forward-looking statements include, without limitation, statements regarding future operations, performance, financial condition, prospects, plans and strategies. These forward-looking statements are based on current expectations and assumptions that may prove to be incorrect. Risks and uncertainties exist that may cause results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include, without limitation: interest rate fluctuations; changes in conditions of the real estate markets; volatility in the capital markets; unfavorable economic conditions; impairments in the company’s goodwill or other intangible assets; failures at financial institutions where the company deposits funds; regulatory oversight and changes in applicable laws and government regulations, including privacy and data protection laws; heightened scrutiny by legislators and regulators of the company’s title insurance and services segment and certain other of the company’s businesses; regulation of title insurance rates; limitations on access to public records and other data; severe weather conditions, health crises, terrorist attacks and other catastrophes; changes in relationships with large mortgage lenders and government-sponsored enterprises; changes in measures of the strength of the company’s title insurance underwriters, including ratings and statutory capital and surplus; losses in the company’s investment portfolio or venture investment portfolio; material variance between actual and expected claims experience; provision of capital to subsidiaries that could affect the company’s liquidity position; defalcations, increased claims or other costs and expenses attributable to the company’s use of title agents; any inadequacy in the company’s risk management framework or use of models; systems damage, failures, interruptions, cyberattacks and intrusions, or unauthorized data disclosures; innovation efforts of the company and other industry participants and any related market disruption; errors and fraud involving the transfer of funds; failures to recruit and retain qualified employees; the company’s use of a global workforce; inability of the company to fulfill parent company obligations and/or pay dividends; inability to realize anticipated synergies or produce returns that justify investment in acquired businesses; a reduction in the deposits at the company’s federal savings bank subsidiary; claims of infringement or inability to adequately protect the company’s intellectual property; and other factors described in the company’s annual report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission. The forward-looking statements speak only as of the date they are made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Use of Non-GAAP Financial Measures

This news release and related management commentary contain certain financial measures that are not presented in accordance with generally accepted accounting principles (GAAP), including an adjusted debt to capitalization ratio, personnel and other operating expense ratios, success ratios, net operating revenues; and adjusted revenues, adjusted pretax income, adjusted pretax margin, adjusted net income, and adjusted earnings per share. The company is presenting these non-GAAP financial measures because they provide the company’s management and investors with additional insight into the financial leverage, operational efficiency and performance of the company relative to earlier periods and relative to the company’s competitors. The company does not intend for these non-GAAP financial measures to be a substitute for any GAAP financial information. In this news release, these non-GAAP financial measures have been presented with, and reconciled to, the most directly comparable GAAP financial measures. Investors should use these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures.

First American Financial Corporation
Summary of Consolidated Financial Results and Selected Information
(in millions, except per share amounts and title orders, unaudited)


	Three Months Ended
	March 31,
	2026			2025
Total revenues	$	1,838.0		$	1,582.3

Income before income taxes	$	161.8		$	96.6
Income tax expense		37.0			21.8
Net income		124.8			74.8
Less: Net (loss) income attributable to noncontrolling interests		(0.3	)		0.6
Net income attributable to the Company	$	125.1		$	74.2

Net income per share attributable to stockholders:
Basic	$	1.21		$	0.72
Diluted	$	1.21		$	0.71

Cash dividends declared per share	$	0.55		$	0.54

Weighted average common shares outstanding:
Basic		103.0			103.8
Diluted		103.3			104.2

Selected Title Insurance Segment Information
Title orders opened⁽¹⁾		182,900			168,900
Title orders closed⁽¹⁾		119,900			110,300
Paid title claims	$	41.7		$	38.4

(1) U.S. direct title insurance orders only.

First American Financial Corporation
Selected Consolidated Balance Sheet Information
(in millions, unaudited)


	March 31,		December 31,
	2026		2025
Cash and cash equivalents	$	2,436.2	$	1,387.3
Investments		9,930.2		9,394.3
Goodwill and other intangible assets, net		1,912.9		1,919.3
Total assets		17,936.6		16,228.8
Reserve for claim losses		1,166.3		1,169.6
Notes and contracts payable		1,545.2		1,545.4
Total stockholders’ equity	$	5,489.6	$	5,499.5

First American Financial Corporation
Segment Information
(in millions, unaudited)

Three Months Ended				Title			Home			Corporate
March 31, 2026	Consolidated			Insurance			Warranty			(incl. Elims.)
Revenues
Direct premiums and escrow fees	$	660.2		$	557.1		$	103.1		$	0.0
Agent premiums		759.4			759.4			—			—
Information and other		275.1			269.2			5.9			0.0
Net investment income (loss)		152.4			154.2			1.3			(3.1	)
Net investment gains (losses)		(9.1	)		(7.6	)		(0.5	)		(1.0	)
		1,838.0			1,732.3			109.8			(4.1	)
Expenses
Personnel costs		568.2			546.4			21.0			0.8
Premiums retained by agents		602.2			602.2			—			—
Other operating expenses		310.4			277.4			23.3			9.7
Provision for policy losses and other claims		77.8			39.5			37.2			1.1
Depreciation and amortization		54.6			53.1			1.4			0.1
Premium taxes		21.1			20.0			1.1			0.0
Interest		41.9			26.7			—			15.2
		1,676.2			1,565.3			84.0			26.9
Income (loss) before income taxes	$	161.8		$	167.0		$	25.8		$	(31.0	)

Three Months Ended				Title			Home			Corporate
March 31, 2025	Consolidated			Insurance			Warranty			(incl. Elims.)
Revenues
Direct premiums and escrow fees	$	561.1		$	459.6		$	101.6		$	(0.1	)
Agent premiums		654.6			654.6			—			—
Information and other		242.2			236.0			6.2			(0.0	)
Net investment income (loss)		135.2			137.7			0.8			(3.3	)
Net investment gains (losses)		(10.8	)		(3.5	)		(0.8	)		(6.5	)
		1,582.3			1,484.4			107.8			(9.9	)
Expenses
Personnel costs		506.7			484.8			20.5			1.4
Premiums retained by agents		525.5			525.5			—			—
Other operating expenses		278.3			246.4			22.5			9.4
Provision for policy losses and other claims		70.1			33.4			37.7			(1.0	)
Depreciation and amortization		52.5			51.2			1.3			(0.0	)
Premium taxes		17.4			16.3			1.1			(0.0	)
Interest		35.2			20.0			—			15.2
		1,485.7			1,377.6			83.1			25.0
Income (loss) before income taxes	$	96.6		$	106.8		$	24.7		$	(34.9	)

First American Financial Corporation
Reconciliation of Non-GAAP Financial Measures
(in millions, except margin and per share amounts, unaudited)
Consolidated

	Three Months Ended
	March 31,
	2026			2025

Total revenues	$	1,838.0		$	1,582.3
Non-GAAP adjustments:
Less: Net investment gains (losses)		(9.1	)		(10.8	)
Adjusted total revenues	$	1,847.1		$	1,593.1

Pretax income	$	161.8		$	96.6
Non-GAAP adjustments:
Less: Net investment gains (losses)		(9.1	)		(10.8	)
Plus: Purchase-related intangible amortization		6.7			6.8
Adjusted pretax income	$	177.6		$	114.2

Pretax margin		8.8	%		6.1	%
Non-GAAP adjustments:
Less: Net investment gains (losses)		(0.5	)%		(0.6	)%
Plus: Purchase-related intangible amortization		0.3	%		0.5	%
Adjusted pretax margin		9.6	%		7.2	%

Net income	$	125.1		$	74.2
Non-GAAP adjustments, net of tax:
Less: Net investment gains (losses)		(7.0	)		(8.4	)
Plus: Purchase-related intangible amortization		5.2			5.3
Adjusted net income	$	137.3		$	87.9

Earnings per diluted share (EPS)	$	1.21		$	0.71
Non-GAAP adjustments, net of tax:
Less: Net investment gains (losses)	$	(0.07	)	$	(0.08	)
Plus: Purchase-related intangible amortization	$	0.05		$	0.05
Adjusted EPS	$	1.33		$	0.84


Purchase-related intangible amortization includes amortization of noncompete agreements, customer relationships, and trademarks acquired in business combinations.

Totals may not sum due to rounding.

First American Financial Corporation
Reconciliation of Non-GAAP Financial Measures
(in millions except margin, unaudited)
By Segment

	Three Months Ended
	March 31,
	2026			2025
Title Insurance and Services Segment
Total revenues	$	1,732.3		$	1,484.4
Non-GAAP adjustments:
Less: Net investment gains (losses)		(7.6	)		(3.5	)
Adjusted total revenues	$	1,739.9		$	1,487.9

Pretax income	$	167.0		$	106.8
Non-GAAP adjustments:
Less: Net investment gains (losses)		(7.6	)		(3.5	)
Plus: Purchase-related intangible amortization		6.7			6.8
Adjusted pretax income	$	181.3		$	117.1

Pretax margin		9.6	%		7.2	%
Non-GAAP adjustments:
Less: Net investment gains (losses)		(0.4	)%		(0.2	)%
Plus: Purchase-related intangible amortization		0.4	%		0.5	%
Adjusted pretax margin		10.4	%		7.9	%

Home Warranty Segment
Total revenues	$	109.8		$	107.8
Non-GAAP adjustments:
Less: Net investment gains (losses)		(0.5	)		(0.8	)
Adjusted total revenues	$	110.3		$	108.6

Pretax income	$	25.8		$	24.7
Non-GAAP adjustments:
Less: Net investment gains (losses)		(0.5	)		(0.8	)
Adjusted pretax income	$	26.3		$	25.5

Pretax margin		23.5	%		22.9	%
Non-GAAP adjustments:
Less: Net investment gains (losses)		(0.3	)%		(0.6	)%
Adjusted pretax margin		23.8	%		23.5	%


Purchase-related intangible amortization includes amortization of noncompete agreements, customer relationships, and trademarks acquired in business combinations.

Totals may not sum due to rounding.

First American Financial Corporation
Expense and Success Ratio Reconciliation
Title Insurance and Services Segment
($ in millions, unaudited)


	Three Months Ended
	March 31,
	2026			2025
Total revenues	$	1,732.3		$	1,484.4
Less: Net investment gains (losses)		(7.6	)		(3.5	)
Net investment income (loss)		154.2			137.7
Premiums retained by agents		602.2			525.5
Net operating revenues	$	983.5		$	824.7


Personnel and other operating expenses	$	823.8		$	731.2
Ratio (% net operating revenues)		83.8	%		88.7	%
Ratio (% total revenues)		47.6	%		49.3	%


Change in net operating revenues	$	158.8
Change in personnel and other operating expenses		92.6
Success Ratio⁽¹⁾		58	%

(1) Change in personnel and other operating expenses divided by change in net operating revenues.

First American Financial Corporation
Supplemental Direct Title Insurance Order Information⁽¹⁾
(unaudited)


	Q126			Q425			Q325			Q225			Q125
Open Orders per Day
Purchase		1,429			1,100			1,375			1,554			1,491
Refinance		838			768			771			623			566
Refinance as % of residential orders		37	%		41	%		36	%		29	%		28	%
Commercial		451			444			441			437			436
Default and other		280			346			402			307			277
Total open orders per day		2,998			2,657			2,989			2,920			2,769

Closed Orders per Day
Purchase		839			953			1,062			1,110			893
Refinance		616			629			503			494			393
Refinance as % of residential orders		42	%		40	%		32	%		31	%		31	%
Commercial		249			289			238			240			230
Default and other		262			375			413			318			292
Total closed orders per day		1,966			2,246			2,216			2,161			1,807

Average Revenue per Order (ARPO)⁽²⁾
Purchase	$	3,740		$	3,704		$	3,689		$	3,693		$	3,643
Refinance		1,130			1,146			1,034			998			1,002
Commercial		17,851			18,605			16,119			15,267			13,123
Default and other		126			366			343			539			394

Total ARPO	$	4,229		$	4,350		$	3,801		$	3,897		$	3,747

Business Days		61			63			64			64			61

(1) U.S. operations only.

(2) Average revenue per order (ARPO) defined as direct premiums and escrow fees divided by closed title orders.
Please note that during the fourth quarter of 2025, the company revised refinance order counts and corresponding total order counts for all periods prior to the third quarter of 2025, which impacted all related year-over-year metrics, due to certain home equity orders that were previously excluded. These revised order counts also impacted ARPO previously reported in earnings releases for the periods prior to the third quarter of 2025; however, there was no change to reported revenues.

Totals may not sum due to rounding.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422259888/en/

Media Contact:

Marcus Ginnaty

Corporate Communications

First American Financial Corporation

714-250-3298

Investor Contact:

Craig Barberio

Investor Relations

First American Financial Corporation

714-250-5214

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property Insurance Finance Banking Professional Services Other Construction & Property Residential Building & Real Estate

MEDIA:

Logo

April 22, 2026 4:41 pm

Eagle Bancorp, Inc. Announces First Quarter 2026 Results and Cash Dividend

BETHESDA, Md., April 22, 2026 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (“Eagle” or the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for EagleBank, one of the largest community banks in the Washington D.C. area, reported its unaudited results for the first quarter ended March 31, 2026.

Eagle reported a net income of $14.7 million or $0.48 per share for the first quarter 2026, compared to a net loss of $2.4 million or $(0.08) per share for the fourth quarter of 2025. The $17.1 million improvement from the prior quarter is primarily due to a $14.7 million decrease in noninterest expense related to lower loan disposition expenses, a $10 million legal provision that did not reoccur in the first quarter, and a $2.1 million lower provision for credit losses. This benefit from a decline in noninterest expense and a lower provision was partially offset by a $4.6 million reduction in net interest income and a $3.9 million increase in the tax expense.

Pre-provision net revenue (“PPNR”)¹ also improved in the first quarter to $27.7 million compared to $10.7 million for the prior quarter reflecting the noninterest expense and net interest income factors discussed above.

“We are pleased to begin the year with meaningful progress against our near-term strategic priorities, including asset quality improvement, capital accretion through earnings, and continued diversification of our balance sheet across both assets and funding sources.” said Susan G. Riel, President, and Chief Executive Officer of the Company.

“Our first quarter results reflect the resiliency of our franchise and the deliberate work underway to reposition it. We delivered strong C&I growth, returned to profitability, expanded net interest margin, and meaningfully reduced our reliance on wholesale funding. Our CRE concentration declined below 300%, and criticized and classified balances continued their downward trajectory. At the same time, we recognize that our current level of profitability does not yet reflect the earnings power of this franchise, and we are focused on executing against a clear plan to expand pre-provision net revenue over the course of 2026.” Ms. Riel added.

Additionally, the Company is announcing today a cash dividend in the amount of $0.01 per share. The cash dividend will be payable on May 15, 2026 to shareholders of record on May 4, 2026.

___________________________

¹ A reconciliation of non-GAAP financial measures and the nearest GAAP measures is provided in the GAAP Reconciliation to Non-GAAP Financial Measures tables that accompany this document.

First Quarter of 2026 Key Elements

The Company announces today the declaration of a common stock dividend of $0.01 per share.
Total C&I loans (including owner-occupied) increased $157.7 million or 5.2%, and C&I deposits decreased $238.0 million, or 11.4% from the previous quarter. Year-over-year period end C&I deposit growth totaled $400.6 million or 28%.
In the first quarter of 2026 the Bank’s CRE concentration ratio was 295.1% compared to 336.6% the prior quarter. ADC concentration at March 31 was 75.7% compared to 92.1% at December 31, 2025.
The ACL as a percentage of total loans was 2.12% at quarter-end; down from 2.19% at the prior quarter-end. Performing office coverage² was 7.39% at quarter-end; as compared to 12.89% at the prior quarter-end, primarily due to a decrease in the qualitative reserve for CRE office loans (“office overlay”) as the CRE office portfolio decreased and improved in risk ratings.
Nonperforming assets increased by $21.9 million to $130.8 million as of March 31, 2026, representing 1.31% of total assets, compared to $109.0 million, representing 1.04% of total assets as of December 31, 2025. During the quarter, nonperforming loan inflows totaled $61.6 million. Reductions of $39.8 million reflected underlying collateral liquidations and sales of loans.
Including loans held for sale, substandard and special mention loans totaled $794.1 million at March 31, 2026, compared to $874.0 million in the prior quarter. Substandard and special mention loans held for sale totaled $55.2 million and $90.7 million at March 31, 2026 and December 31, 2025, respectively.
Annualized quarterly net charge-offs for the first quarter of 2026 were 1.46% compared to 0.67% for the fourth quarter of 2025.
The net interest margin (“NIM”) increased to 2.47% for the first quarter of 2026, compared to 2.38% for the prior quarter, primarily driven by improved funding mix as core deposit inflows and reduced brokered deposit usage lowered cost of funds. This improvement was partially offset by lower interest income from declines in cash and loan average balances.
At quarter-end, the common equity ratio, tangible common equity ratio¹, and common equity tier 1 capital (to risk-weighted assets) ratio were 11.51%, 11.51%, and 13.80%, respectively.
Total estimated insured deposits decreased at quarter-end to $6.4 billion, representing 74.2% of deposits, compared to $6.9 billion, or 75.3% in the prior quarter. This decrease was primarily due to reduced usage of brokered deposits.
Total on-balance sheet liquidity and available capacity was $4.3 billion, compared to $2.2 billion in uninsured deposits, resulting in a coverage ratio of over 195%.

___________________________

¹ A reconciliation of non-GAAP financial measures and the nearest GAAP measures is provided in the GAAP ²Reconciliation to Non-GAAP Financial Measures tables that accompany this document. Calculated as the ACL attributable to loans collateralized by performing office properties as a percentage of total office loans.

Income Statement

Net interest income was $63.7 million for the first quarter of 2026, compared to $68.3 million for the prior quarter. Both interest income and interest expense declined during the quarter, reflecting the impact of declining average interest-earning balances, lower yields and fewer days in the quarter.
Provision for credit losses was $13.4 million for the first quarter of 2026, compared to $15.5 million for the prior quarter. The decrease was primarily driven by a decrease in the qualitative office overlay partially offset by updated quantitative assumptions used to calculate our current expected credit losses. The provision related to the reserve for unfunded commitments was a reversal of $1.8 million, compared to a provision expense of $203 thousand in the prior quarter.
Noninterest income was increased $0.5 million to $12.7 million for the first quarter of 2026, compared to $12.2 million for the prior quarter. In the quarter, gain on the sale of loans totaled $3.6 million as compared to a loss on sale of loans in the linked period of $1.1 million.
Noninterest expense was $48.7 million for the first quarter of 2026, compared to $69.8 million for the prior quarter. The decrease over the linked quarter was primarily due to $14.7 million decrease in expenses related to loan dispositions, as well as a $10 million legal provision, in the prior quarter that did not reoccur in the first quarter of 2026.
Income tax
expense was $1.3 million for the first quarter of 2026, compared to a $2.6 million benefit for the prior quarter. The increase in income tax expense was primarily due to higher pre-tax income during the first quarter of 2026.

Loans and Funding

Total loans, including loans held for sale, were $7.0 billion at March 31, 2026, a decrease of 5% from the prior quarter-end. The decrease in total loans was primarily driven by declines in income-producing real estate loans, partially offset by an increase in commercial and industrial loans.
Total deposits at quarter-end were $8.6 billion, down $0.5 billion, or 6%, from the prior quarter-end. Of the quarter-over-quarter decline, brokered deposits represents $412.7 million. The decrease was primarily driven by lower balances in savings and money market accounts and brokered time deposits. Deposits decreased $685.8 million compared to March 31, 2025.

Asset Quality

Allowance for credit losses was 2.12% of total loans held for investment at March 31, 2026, compared to 2.19% at the prior quarter-end. Performing office coverage was 7.39% at quarter-end; as compared to 12.89% at the prior quarter-end, primarily due to a decrease in the qualitative reserve for office overlay as the CRE office portfolio decreased and improved in risk ratings.
Net charge-offs were $26.0 million for the quarter compared to $12.3 million in the fourth quarter of 2025.
Nonperforming assets (“NPAs”) were $130.8 million at March 31, 2026.
- NPAs as a percentage of assets were 1.31% at March 31, 2026, compared to 1.04% at the prior quarter-end. At March 31, 2026, OREO consisted of three properties with an aggregate carrying value of $2.1 million.
- Loans 30-89 days past due were $18.0 million at March 31, 2026, compared to $49.9 million at the prior quarter-end.

Capital

Total shareholders’ equity was $1.1 billion at March 31, 2026, up 1.2% from the prior quarter-end. The increase in shareholders’ equity of $14.0 million was primarily due to quarterly income that increased capital.
Book value per share and tangible book value per share
³ were $37.56 and $37.56, an increase of 0.8% from the prior quarter-end.

___________________________

³ A reconciliation of non-GAAP financial measures and the nearest GAAP measures is provided in the GAAP Reconciliation to Non-GAAP Financial Measures tables that accompany this document.

Additional financial information: The financial information that follows provides more detail on the Company’s financial performance for the three months ended March 31, 2026 as compared to the three months ended December 31, 2025 and March 31, 2025, as well as eight quarters of trend data. Persons wishing additional information should refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and other reports filed with the SEC.

About Eagle Bancorp: The Company is the holding company for EagleBank, which commenced operations in 1998. The Bank is headquartered in Bethesda, Maryland, and operates through twelve banking offices and four lending offices located in Suburban Maryland, Washington, D.C. and Northern Virginia. The Company focuses on building relationships with businesses, professionals and individuals in its marketplace, and is committed to a culture of respect, opportunity, belonging, and inclusion in both its workplace and the communities in which it operates.

Conference call: Eagle Bancorp will host a conference call to discuss its first quarter of 2026 financial results on Thursday, April 23, 2026 at 10:00 a.m. Eastern Time.

The listen-only webcast can be accessed at:

https://edge.media-server.com/mmc/p/cn74vqnt/
For analysts who wish to participate in the conference call, please register at the following URL:
https://register-conf.media-server.com/register/BI435096520d554131b588151b80b05bdf

A replay of the conference call will be available on the Company’s website through Thursday, May 7, 2026: https://www.eaglebankcorp.com/

Forward-looking statements: This press release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended, including statements of goals, intentions, and expectations as to future trends, plans, events, financial condition, asset quality or results of Company operations and policies and regarding general economic conditions. In some cases, forward-looking statements can be identified by use of words such as “may,” “will,” “can,” “anticipates,” “believes,” “expects,” “plans,” “strategy,” “estimates,” “potential,” “continue,” “should,” “could,” “strive,” “feel” and similar words or phrases. These statements are based upon current and anticipated economic conditions, nationally and in the Company’s market (including reductions in the size of the federal government workforce; changes in government spending; the economic effects of an extended government shutdown; the proposal, announcement or imposition of tariffs; volatility in interest rates and interest rate, monetary and fiscal policy; inflation levels; competitive factors; our ability to access cost-effective funding) and other conditions (such as the impact of bank failures, credit losses or adverse developments at other banks and related negative press about the banking industry in general on investor and depositor sentiment regarding the stability and liquidity of banks), which by their nature are not susceptible to accurate forecast and are subject to significant uncertainty. Because of these uncertainties and the assumptions on which this discussion and the forward-looking statements are based, actual future operations and results in the future may differ materially from those indicated herein. For details on factors that could affect these expectations, see the risk factors and other cautionary language included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in other periodic and current reports filed with the SEC, including the Company’s Quarterly Reports on Form 10-Q. Readers are cautioned against placing undue reliance on any such forward-looking statements. The Company’s past results are not necessarily indicative of future performance. All information is as of the date of this press release. Any forward-looking statements made by or on behalf of the Company speak only as to the date they are made. Except to the extent required by applicable law or regulation, the Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

Eagle Bancorp, Inc.
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share data)

	Three Months Ended
	March 31,			December 31,			March 31,
	2026			2025			2025
Interest Income
Interest and fees on loans	$	109,566		$	119,744		$	126,136
Interest and dividends on investment securities		9,646			10,083			11,912
Interest on balances with other banks and short-term investments		12,689			19,699			15,830
Total interest income		131,901			149,526			153,878
Interest Expense
Interest on deposits		66,181			79,147			77,211
Interest on customer repurchase agreements		—			52			260
Interest on other short-term borrowings		—			—			8,733
Interest on long-term borrowings		2,026			2,024			2,025
Total interest expense		68,207			81,223			88,229
Net Interest Income		63,694			68,303			65,649
Provision for Credit Losses		13,382			15,468			26,255
Provision (Reversal) for Credit Losses for Unfunded Commitments		(1,779	)		203			(297	)
Net Interest Income (Loss) After Provision for Credit Losses		52,091			52,632			39,691

Noninterest Income
Service charges on deposits		1,732			1,840			1,743
Gain (loss) on sale of loans		3,550			(1,137	)		—
Net gain (loss) on sale of investment securities		3			9			4
Increase in cash surrender value of bank-owned life insurance		5,679			5,636			4,282
Other income		1,744			5,844			2,178
Total noninterest income		12,708			12,192			8,207
Noninterest Expense
Salaries and employee benefits		23,247			22,661			21,968
Premises and equipment expenses		2,533			2,861			3,203
Marketing and advertising		868			1,185			1,371
Data processing		4,204			4,353			3,978
Legal, accounting and professional fees		4,312			3,100			3,122
FDIC insurance		7,009			7,709			8,962
Legal Contingency		—			10,000			—
Other expenses		6,567			17,968			2,847
Total noninterest expense		48,740			69,837			45,451
Income (Loss) Before Income Tax Expense		16,059			(5,013	)		2,447
Income Tax Expense (Benefit)		1,341			(2,574	)		772
Net Income (Loss)	$	14,718		$	(2,439	)	$	1,675

Earnings (Loss) Per Common Share
Basic	$	0.48		$	(0.08	)	$	0.06
Diluted	$	0.48		$	(0.08	)	$	0.06

Eagle Bancorp, Inc.
Consolidated Balance Sheets (Unaudited)
(Dollars in thousands, except per share data)
	March 31,			December 31,			March 31,
	2026			2025			2025
Assets
Cash and due from banks	$	12,626		$	11,692		$	15,484
Interest-bearing deposits with banks and other short-term investments		566,733			684,001			661,173
Investment securities available-for-sale at fair value (amortized cost of $1,008,764, $1,055,146, and $1,330,077 respectively, and allowance for credit losses of $—, $—, and $—, respectively)		930,314			976,770			1,214,237
Investment securities held-to-maturity at amortized cost, net of allowance for credit losses of $907, $1,030, and $1,275 respectively (fair value of $757,238, $786,662, and $774,947 respectively)		841,273			854,780			924,473
Federal Reserve and Federal Home Loan Bank stock		27,685			28,327			51,467
Loans held for sale, at lower of cost or fair value		55,702			90,650			15,251
Loans held for investment, at amortized cost		6,938,560			7,280,459			7,943,306
Less: allowance for credit losses		(147,163	)		(159,604	)		(129,469	)
Loans held for investment, net of allowance		6,791,397			7,120,855			7,813,837
Premises and equipment, net		12,864			12,800			7,079
Operating lease right-of-use assets		27,569			28,451			32,769
Deferred income taxes		132,729			132,330			84,798
Bank-owned life insurance		339,844			335,177			320,055
Other real estate owned		2,059			2,059			2,459
Other assets		213,486			219,311			174,279
Total Assets	$	9,954,281		$	10,497,203		$	11,317,361
Liabilities and Shareholders’ Equity
Liabilities
Deposits:
Noninterest-bearing demand	$	1,488,668		$	1,433,952		$	1,607,826
Interest-bearing transaction		978,330			1,038,154			926,722
Savings and money market		3,286,125			3,624,813			3,558,919
Time deposits		2,838,376			3,036,687			3,183,801
Total deposits		8,591,499			9,133,606			9,277,268
Customer repurchase agreements		—			—			32,357
Other short-term borrowings		—			—			490,000
Long-term borrowings		76,511			76,428			76,181
Operating lease liabilities		34,532			35,256			38,484
Reserve for unfunded commitments		3,311			5,090			3,166
Other liabilities		103,151			115,540			155,014
Total Liabilities		8,809,004			9,365,920			10,072,470
Shareholders’ Equity
Common stock, par value $0.01 per share; shares authorized 100,000,000, shares issued and outstanding 30,494,659, 30,359,632, and 30,368,843 respectively		302			300			300
Additional paid-in capital		383,050			382,499			386,535
Retained earnings		851,998			837,643			978,995
Accumulated other comprehensive loss		(90,073	)		(89,159	)		(120,939	)
Total Shareholders’ Equity		1,145,277			1,131,283			1,244,891
Total Liabilities and Shareholders’ Equity	$	9,954,281		$	10,497,203		$	11,317,361

Loan Mix and Asset Quality
(Dollars in thousands)

	March 31,				December 31,				March 31,
	2026				2025				2025
	Amount		%		Amount		%		Amount		%
Loan Balances – Period End:
Commercial	$	1,432,933	21	%	$	1,338,486	18	%	$	1,178,569	15	%
Income producing – commercial real estate		3,030,004	44	%		3,350,718	46	%	$	3,967,124	49	%
Owner occupied – commercial real estate		1,686,210	23	%		1,602,124	22	%	$	1,403,668	18	%
Real estate mortgage – residential		35,743	1	%		37,100	1	%	$	48,821	1	%
Construction – commercial and residential		617,992	9	%		795,400	11	%	$	1,210,788	15	%
Construction – C&I (owner occupied)		87,666	1	%		108,468	1	%	$	83,417	1	%
Home equity		44,948	1	%		47,448	1	%	$	50,121	1	%
Other consumer		3,064	—	%		715	—	%	$	798	—	%
Total loans	$	6,938,560	100	%	$	7,280,459	100	%	$	7,943,306	100	%

	Three Months Ended or As Of
	March 31,		December 31,		March 31,
	2026		2025		2025
Asset Quality:
Nonperforming loans	$	128,761	$	106,897	$	200,447
Other real estate owned		2,059		2,059		2,459
Nonperforming assets	$	130,820	$	108,956	$	202,906
Net charge-offs	$	25,960	$	12,259	$	11,230
Special mention	$	290,827	$	268,881	$	273,380
Substandard	$	447,604	$	514,497	$	501,565

Eagle Bancorp, Inc.
Consolidated Average Balances, Interest Yields And Rates vs. Prior Quarter (Unaudited)
(Dollars in thousands)

	Three Months Ended
	March 31, 2026							December 31, 2025
	Average Balance			Interest		Average Yield/ Rate		Average Balance			Interest		Average Yield/ Rate
Assets
Interest earning assets:
Interest-bearing deposits with other banks and other short-term investments	$	1,420,918		$	12,689	3.62	%	$	1,997,019		$	19,770	3.93	%
Loans held for sale ⁽¹⁾		85,096			1,380	6.58	%		135,981			1,626	4.74	%
Loans ^{(1) (2)}		7,112,483			108,185	6.17	%		7,338,320			118,118	6.39	%
Investment securities available-for-sale ⁽²⁾		988,390			5,187	2.13	%		1,050,620			5,501	2.08	%
Investment securities held-to-maturity ⁽²⁾		849,802			4,460	2.13	%		867,222			4,582	2.10	%
Total interest earning assets		10,456,689			131,901	5.12	%		11,389,162			149,597	5.21	%

Noninterest earning assets		734,996							733,464
Less: allowance for credit losses		(161,755	)						(157,925	)
Total noninterest earning assets		573,241							575,539
Total Assets	$	11,029,930						$	11,964,701

Liabilities and Shareholders’ Equity
Interest bearing liabilities:
Interest-bearing transaction	$	1,462,553		$	9,317	2.58	%	$	1,574,757		$	11,055	2.79	%
Savings and money market		3,437,234			25,851	3.05	%		3,931,453			33,040	3.33	%
Time deposits		2,934,494			30,957	4.28	%		3,163,520			35,052	4.40	%
Total interest bearing deposits		7,834,281			66,125	3.42	%		8,669,730			79,147	3.62	%
Customer repurchase agreements		—			—	—	%		6,656			53	3.16	%
Derivative collateral liability		7,745			56	2.98	%		6,200			70	4.48	%
Long-term borrowings		76,483			2,026	10.73	%		76,400			2,024	10.51	%
Total interest bearing liabilities		7,918,509			68,207	3.49	%		8,758,986			81,294	3.68	%
Noninterest bearing liabilities:
Noninterest bearing demand		1,817,726							1,920,522
Other liabilities		146,110							144,791
Total noninterest bearing liabilities		1,963,836							2,065,313
Shareholders’ equity		1,147,585							1,140,402
Total Liabilities and Shareholders’ Equity	$	11,029,930						$	11,964,701
Net interest income				$	63,694						$	68,303
Net interest spread						1.63	%						1.53	%
Net interest margin						2.47	%						2.38	%
Cost of funds						2.84	%						3.02	%

⁽¹⁾Loans placed on nonaccrual status are included in average balances. Net loan fees and late charges included in interest income on loans totaled $3.9 million and $3.9 million for the three months ended March 31, 2026 and December 31, 2025, respectively.
⁽²⁾Interest and fees on loans and investments exclude tax equivalent adjustments.

Eagle Bancorp, Inc.
Consolidated Average Balances, Interest Yields And Rates vs. Year Ago Quarter (Unaudited)
(Dollars in thousands)

	Three Months Ended March 31,
		2026							2025
	Average Balance			Interest		Average Yield/ Rate		Average Balance			Interest		Average Yield/ Rate
Assets
Interest earning assets:
Interest-bearing deposits with other banks and other short-term investments	$	1,420,918		$	12,689	3.62	%	$	1,450,464		$	15,830	4.43	%
Loans held for sale ⁽¹⁾		85,096			1,380	6.58	%		169			—	—	%
Loans ^{(1) (2)}		7,112,483			108,185	6.17	%		7,933,695			126,136	6.45	%
Investment securities available-for-sale ⁽²⁾		988,390			5,187	2.13	%		1,321,954			6,857	2.10	%
Investment securities held-to-maturity ⁽²⁾		849,802			4,460	2.13	%		933,880			5,055	2.20	%
Total interest earning assets		10,456,689			131,901	5.12	%		11,640,162			153,878	5.36	%

Noninterest earning assets		734,996							596,585
Less: allowance for credit losses		(161,755	)						(118,557	)
Total noninterest earning assets		573,241							478,028
Total Assets	$	11,029,930						$	12,118,190

Liabilities and Shareholders’ Equity
Interest bearing liabilities:
Interest-bearing transaction	$	1,462,553		$	9,317	2.58	%	$	1,368,609		$	9,908	2.94	%
Savings and money market		3,437,234			25,851	3.05	%		3,682,217			32,389	3.57	%
Time deposits		2,934,494			30,957	4.28	%		2,951,111			34,914	4.80	%
Total interest bearing deposits		7,834,281			66,125	3.42	%		8,001,937			77,211	3.91	%
Customer repurchase agreements		—			—	—	%		36,572			260	2.88	%
Derivative collateral liability		7,745			56	2.98	%		—			—	—	%
Other short-term borrowings		—			—	—	%		682,222			8,733	5.19	%
Long-term borrowings		76,483			2,026	10.73	%		76,146			2,025	10.79	%
Total interest bearing liabilities		7,918,509			68,207	3.49	%		8,796,877			88,229	4.07	%
Noninterest bearing liabilities:
Noninterest bearing demand		1,817,726							1,881,296
Other liabilities		146,110							197,212
Total noninterest bearing liabilities		1,963,836							2,078,508
Shareholders’ equity		1,147,585							1,242,805
Total Liabilities and Shareholders’ Equity	$	11,029,930						$	12,118,190
Net interest income				$	63,694						$	65,649
Net interest spread						1.63	%						1.29	%
Net interest margin						2.47	%						2.28	%
Cost of funds						2.84	%						3.35	%

⁽¹⁾Loans placed on nonaccrual status are included in average balances. Net loan fees and late charges included in interest income on loans totaled $3.9 million and $3.8 million for the three months ended March 31, 2026 and 2025, respectively.
⁽²⁾Interest and fees on loans and investments exclude tax equivalent adjustments.

Eagle Bancorp, Inc.
Statements of Operations and Highlights Quarterly Trends (Unaudited)
(Dollars in thousands, except per share data)
	Three Months Ended
	March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025			December 31, 2024			September 30, 2024			June 30, 2024
Income Statements:
Total interest income	$	131,901		$	149,526		$	150,103		$	151,443		$	153,878		$	168,417		$	173,813		$	169,731
Total interest expense		68,207			81,223			81,944			83,667			88,229			97,623			101,970			98,378
Net interest income		63,694			68,303			68,159			67,776			65,649			70,794			71,843			71,353
Provision for credit losses		13,382			15,468			113,215			138,159			26,255			12,132			10,094			8,959
Provision (reversal) for credit losses for unfunded commitments		(1,779	)		203			(38	)		1,759			(297	)		(1,598	)		(1,593	)		608
Net interest income after provision for credit losses		52,091			52,632			(45,018	)		(72,142	)		39,691			60,260			63,342			61,786
Noninterest income before investment gain		12,705			12,183			4,477			8,268			8,203			4,063			6,948			5,329
Net gain (loss) on sale of investment securities		3			9			(1,982	)		(1,854	)		4			4			3			3
Total noninterest income		12,708			12,192			2,495			6,414			8,207			4,067			6,951			5,332
Salaries and employee benefits		23,247			22,661			21,290			21,940			21,968			22,597			21,675			21,770
Premises and equipment expenses		2,533			2,861			2,944			3,019			3,203			2,635			2,794			2,894
Marketing and advertising		868			1,185			1,316			1,144			1,371			1,340			1,588			1,662
Legal Contingency		—			10,000			—			—			—			—			—			—
Other expenses		22,092			33,130			16,347			17,367			18,909			17,960			17,557			120,165
Total noninterest expense		48,740			69,837			41,897			43,470			45,451			44,532			43,614			146,491
Income (loss) before income tax expense		16,059			(5,013	)		(84,420	)		(109,198	)		2,447			19,795			26,679			(79,373	)
Income tax expense		1,341			(2,574	)		(16,907	)		(39,423	)		772			4,505			4,864			4,429
Net income (loss)		14,718			(2,439	)		(67,513	)		(69,775	)		1,675			15,290			21,815			(83,802	)
Per Share Data:
Earnings (loss) per weighted average common share, basic	$	0.48		$	(0.08	)	$	(2.22	)	$	(2.30	)	$	0.06		$	0.51		$	0.72		$	(2.78	)
Earnings (loss) per weighted average common share, diluted	$	0.48		$	(0.08	)	$	(2.22	)	$	(2.30	)	$	0.06		$	0.50		$	0.72		$	(2.78	)
Weighted average common shares outstanding, basic		30,422,259			30,368,432			30,367,997			30,373,167			30,275,001			30,199,433			30,173,852			30,185,609
Weighted average common shares outstanding, diluted		30,540,379			30,584,374			30,367,997			30,510,847			30,404,262			30,321,644			30,241,699			30,185,609
Actual shares outstanding at period end		30,494,659			30,359,632			30,366,555			30,364,983			30,368,843			30,202,003			30,173,200			30,180,482
Book value per common share at period end	$	37.56		$	37.26		$	37.00		$	39.03		$	40.99		$	40.60		$	40.61		$	38.75
Tangible book value per common share at period end⁽¹⁾	$	37.56		$	37.26		$	37.00		$	39.03		$	40.99		$	40.59		$	40.61		$	38.74
Dividend per common share	$	0.010		$	0.010		$	0.010		$	0.165		$	0.165		$	0.165		$	0.165		$	0.45
Performance Ratios (annualized):
Return on average assets		0.54	%		(0.08	)%		(2.31	)%		(2.33	)%		0.06	%		0.48	%		0.70	%		(2.73	)%
Return on average common equity		5.20	%		(0.85	)%		(22.66	)%		(22.35	)%		0.55	%		4.94	%		7.22	%		(26.67	)%
Return on average tangible common equity⁽¹⁾		5.20	%		(0.85	)%		(22.66	)%		(22.35	)%		0.55	%		4.94	%		7.22	%		(28.96	)%
Net interest margin		2.47	%		2.38	%		2.43	%		2.37	%		2.28	%		2.29	%		2.37	%		2.40	%
Efficiency ratio⁽¹⁾⁽²⁾		63.8	%		86.8	%		59.3	%		58.6	%		61.5	%		59.5	%		55.4	%		191.0	%
Other Ratios:
Allowance for credit losses to total loans⁽³⁾		2.12	%		2.19	%		2.14	%		2.38	%		1.63	%		1.44	%		1.40	%		1.33	%
Allowance for credit losses to total nonperforming loans		114.29	%		149.31	%		131.67	%		81.17	%		64.59	%		54.81	%		83.25	%		110.06	%
Nonperforming assets to total assets		1.31	%		1.04	%		1.23	%		2.16	%		1.79	%		1.90	%		1.22	%		0.88	%
Net charge-offs (recoveries) (annualized) to average total loans⁽³⁾		1.46	%		0.67	%		7.36	%		4.22	%		0.57	%		0.48	%		0.26	%		0.11	%
Tier 1 capital (to average assets)		10.63	%		9.72	%		10.40	%		10.63	%		11.11	%		10.74	%		10.77	%		10.58	%
Total capital (to risk weighted assets)		15.05	%		14.33	%		14.83	%		15.27	%		15.86	%		15.86	%		15.51	%		15.07	%
Common equity tier 1 capital (to risk weighted assets)		13.80	%		13.07	%		13.58	%		14.01	%		14.61	%		14.63	%		14.30	%		13.92	%
Tangible common equity ratio⁽¹⁾		11.51	%		10.78	%		10.39	%		11.18	%		11.00	%		11.02	%		10.86	%		10.35	%
Average Balances (in thousands):
Total assets	$	11,029,930		$	11,964,701		$	11,597,399		$	11,989,095		$	12,118,190		$	12,575,722		$	12,360,899		$	12,361,500
Total earning assets		10,456,689			11,389,162			11,137,543			11,487,006			11,640,162			12,303,940			12,072,891			11,953,446
Total loans⁽³⁾		7,112,483			7,338,320			7,648,459			7,942,333			7,933,695			7,971,907			8,026,524			8,003,206
Total deposits		9,652,007			10,590,252			10,163,215			10,226,095			9,883,233			10,056,463			9,344,414			9,225,266
Total borrowings		76,483			83,056			131,225			355,914			794,940			1,118,276			1,654,736			1,721,283
Total shareholders’ equity		1,147,585			1,140,402			1,182,148			1,252,252			1,242,805			1,230,573			1,201,477			1,263,627

(1)   A reconciliation of non-GAAP financial measures to the nearest GAAP measure is provided in the tables that accompany this document.
(2)   Computed by dividing noninterest expense by the sum of net interest income and noninterest income.
(3)   Excludes loans held for sale.

GAAP Reconciliation to Non-GAAP Financial Measures (unaudited)
(dollars in thousands, except per share data)
	Three Months Ended
	March 31,			December 31,			March 31,
	2026			2025			2025
Tangible common equity
Common shareholders’ equity	$	1,145,277		$	1,131,283		$	1,244,891
Less: Intangible assets		—			—			(11	)
Tangible common equity	$	1,145,277		$	1,131,283		$	1,244,880

Tangible common equity ratio
Total assets	$	9,954,281		$	10,497,203		$	11,317,361
Less: Intangible assets		—			—			(11	)
Tangible assets	$	9,954,281		$	10,497,203		$	11,317,350

Tangible common equity ratio		11.51	%		10.78	%		11.00	%

Per share calculations
Book value per common share	$	37.56		$	37.26		$	40.99
Less: Intangible book value per common share	$	—		$	—		$	—
Tangible book value per common share	$	37.56		$	37.26		$	40.99

Shares outstanding at period end		30,494,659			30,359,632			30,368,843

Average tangible common equity
Average common shareholders’ equity	$	1,147,585		$	1,140,391		$	1,242,805
Less: Average intangible assets		—			—			(14	)
Average tangible common equity	$	1,147,585		$	1,140,391		$	1,242,791

Return on average tangible common equity
Net (loss) income	$	14,718		$	(2,439	)	$	1,675
Return on average tangible common equity		5.20	%		(0.85	)%		0.55	%

Efficiency ratio
Net interest income	$	63,694		$	68,303		$	65,649
Noninterest income		12,708			12,192			8,207
Operating revenue	$	76,402		$	80,495		$	73,856
Noninterest expense	$	48,740		$	69,837		$	45,451

Efficiency ratio		63.79	%		86.76	%		61.54	%

Pre-provision net revenue
Net interest income	$	63,694		$	68,303		$	65,649
Noninterest income		12,708			12,192			8,207
Less: Noninterest expense		(48,740	)		(69,837	)		(45,451	)
Pre-provision net revenue	$	27,662		$	10,658		$	28,405

Tangible common equity, tangible common equity to tangible assets (the “tangible common equity ratio”), tangible book value per common share, average tangible common equity, and the annualized return on average tangible common equity are non-GAAP financial measures derived from GAAP based amounts. The Company calculates the tangible common equity ratio by excluding the balance of intangible assets from common shareholders’ equity, or tangible common equity, and dividing by tangible assets. The Company calculates tangible book value per common share by dividing tangible common equity by common shares outstanding, as compared to book value per common share, which the Company calculates by dividing common shareholders’ equity by common shares outstanding. The Company calculates the annualized return on average tangible common equity ratio by dividing net income available to common shareholders by average tangible common equity, which is calculated by excluding the average balance of intangible assets from the average common shareholders’ equity. The Company considers this information important to shareholders as tangible equity is a measure that is consistent with the calculation of capital for bank regulatory purposes, which excludes intangible assets from the calculation of risk based ratios, and as such is useful for investors, regulators, management and others to evaluate capital adequacy and to compare against other financial institutions.

The efficiency ratio is calculated by dividing GAAP noninterest expense by the sum of GAAP net interest income and GAAP noninterest income. The efficiency ratio measures a bank’s overhead as a percentage of its revenue. The Company believes that reporting the non-GAAP efficiency ratio more closely measures its effectiveness of controlling operational activities.

Pre-provision net revenue is a non-GAAP financial measure calculated by subtracting noninterest expenses from the sum of net interest income and noninterest income. The Company considers this information important to shareholders because it illustrates revenue excluding the impact of provisions and reversals to the allowance for credit losses on loans.

For the March 31, 2026 Earnings Presentation, click 1Q2026 EGBN Earnings DECK 3-31-2026 FINAL

EAGLE BANCORP, INC.

CONTACT:
Eric R. Newell
240.497.1796

April 22, 2026 4:40 pm

KKR Real Estate Finance Trust Inc. Reports First Quarter 2026 Results

KKR Real Estate Finance Trust Inc. Reports First Quarter 2026 Results

NEW YORK–(BUSINESS WIRE)–
KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today reported its first quarter 2026 results, which have been posted to the Investor Relations section of KREF’s website at http://www.kkrreit.com/investor-relations/events-and-presentations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422613354/en/

A conference call to discuss KREF’s financial results will be held on Thursday, April 23, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (844) 784-1730 (U.S. callers) or +1 (412) 380-7410 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed at http://www.kkrreit.com/investor-relations/events-and-presentations.

A replay of the live broadcast will be available on KREF’s website or by dialing (855) 669-9658 (U.S. callers) or +1 (412) 317-0088 (non-U.S. callers), pass code 8477736, beginning approximately two hours after the broadcast.

A slide presentation containing supplemental information has also been posted to the Investor Relations section of KREF’s website at http://www.kkrreit.com/investor-relations/events-and-presentations.

About KKR Real Estate Finance Trust Inc.

KREF is a real estate finance company that focuses primarily on originating and acquiring senior loans secured by commercial real estate properties. KREF is externally managed and advised by an affiliate of KKR & Co. Inc. For additional information about KREF, please visit its website at www.kkrreit.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422613354/en/

Investor Relations:

Jack Switala

(212) 763-9048

[email protected]

Media:

Brooke Rustad

(646) 823-0893

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: REIT Finance Professional Services Commercial Building & Real Estate Construction & Property

MEDIA:

Logo

April 22, 2026 4:40 pm

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

MDD: Emerge topline data readout on track for late 2Q 2026; Ascend sites activated with first patient dosing anticipated in 2Q 2026

GAD: Voyage enrollment complete with 214 patients with topline data readout on track for early 3Q 2026; Panorama sample size re-estimation complete and target sample size updated to 200; screening closed with topline readout now expected in late 3Q 2026

PTSD: DT120 ODT program expanded into PTSD with Phase 3 Haven study expected to initiate in 2027

NEW YORK–(BUSINESS WIRE)–
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders, today highlighted the advancement of its DT120 ODT (lysergide tartrate) clinical program and commercial strategy in major depressive disorder (MDD) and generalized anxiety disorder (GAD), with three anticipated topline readouts in the next six months serving as important near-term catalysts. The Company also announced an expansion of the DT120 ODT program with the planned initiation of the Phase 3 Haven study in posttraumatic stress disorder (PTSD).

“We are building Definium to be a leader in psychiatry, focused on delivering a differentiated, scalable franchise for patients with depression, anxiety, and trauma, anchored by DT120 ODT, which we believe could be a best-in-class therapy,” said Rob Barrow, Chief Executive Officer of Definium Therapeutics. “With three pivotal readouts expected over the next six months, we are rapidly establishing comprehensive clinical evidence for DT120 ODT. Together, these trial outcomes will inform our regulatory approach, including an expeditious path to a potential NDA submission. We continue to execute with focus and urgency to deliver transformative treatments for patients and sustained value for shareholders.”

The Company is preparing for its next phase of growth with the same rigor and discipline that have underpinned the clinical development of DT120 ODT, which represents a potential multi-billion-dollar commercial opportunity supported by a differentiated therapeutic profile and broad applicability across care settings. Definium is advancing a focused, patient-centric commercial strategy, including a scalable delivery model designed to support efficient adoption and long-term utilization. In parallel, the Company is proactively positioning for access and reimbursement with plans to leverage established and emerging practice patterns and existing administrative pathways to enable timely market uptake.

Clinical Advancements

DT120 ODT (lysergide tartrate) for MDD

Emerge: Fully enrolled with 149 participants randomized 1:1 to receive DT120 ODT 100 µg or placebo. Topline data on track for late 2Q 2026.
Ascend: Sites activated with first dosing anticipated in 2Q 2026. Study plans to enroll 175 participants randomized 2:1:2 to DT120 ODT 100 µg, DT120 ODT 50 µg control, or placebo.

DT120 ODT (lysergide tartrate) for GAD

Voyage: Fully enrolled with 214 participants randomized 1:1 to receive DT120 ODT 100 µg or placebo. Topline data on track for early 3Q 2026.
Panorama: Blinded sample size re-estimation complete with total target enrollment updated to 200 participants. Current enrollment over 200 participants and screening now closed. Participants randomized 2:1:2 to receive DT120 ODT 100 µg, DT120 ODT 50 µg control, or placebo. Topline data now anticipated in late 3Q 2026 (updated from 2H 2026).

DT120 ODT (lysergide tartrate) for PTSD

Haven: Phase 3 study in PTSD expected to enroll approximately 200 participants randomized 1:1 to receive DT120 ODT or placebo. Primary endpoint in the study is the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at Week 8. Study initiation expected in 2027.

Today’s Investor and Analyst Day featured Definium’s executive leadership team alongside distinguished expert clinicians, who discussed the evolving treatment landscape in psychiatry, persistent unmet need, and emerging opportunities to improve outcomes for patients, as well as the Company’s clinical progress and commercial strategy. Presentation materials from today’s event are available here.

About DT120 (lysergide tartrate) Orally Disintegrating Tablet (ODT)

DT120 ODT is an ergoline derivative belonging to the group of classic serotonergic psychedelics, which acts as a partial agonist at serotonin-2A (5-HT2A) receptors. DT120 ODT is Definium’s proprietary and pharmaceutically optimized formulation of LSD. DT120 ODT is an advanced formulation incorporating Catalent’s Zydis^® ODT fast-dissolve technology, designed to deliver several unique advantages, including faster absorption and onset of transient cognitive, perceptual, and affective changes, improved bioavailability, and a lower incidence of gastrointestinal side effects. Definium is developing DT120 ODT, the tartrate salt form of lysergide, for generalized anxiety disorder (GAD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), and is exploring its potential applications in other serious brain health disorders. Definium maintains a strong foundation to protect and extend the long-term value of the DT120 ODT franchise through a multi-layered intellectual property strategy spanning composition, formulation, and methods-of-use patents.

About Lysergide (LSD)

Lysergide (LSD) is one of the most extensively studied psychopharmaceuticals in history, with over 1,000 published reports.¹First synthesized in 1938 by Swiss chemist Albert Hofmann in his search for active principles from ergot fungus, its profound psychological effects were discovered in 1943, which transformed psychiatric research.¹LSD, a definitional classic psychedelic, temporarily alters perception, cognition, and emotion, is physiologically safe, non-addictive, and isn’t associated with withdrawal.¹ While its precise mechanism of action in the treatment of psychiatric illness is unknown, its acute perceptual, cognitive, and affective effects are mediated by agonism of the serotonin 5-hydroxytryptamine 2A (5-HT2A) receptor, and mechanistic hypotheses suggest that it causes sustained increases in neuroplasticity in a variety of brain regions.^2,3

About Definium Therapeutics

The mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Forward-Looking Statements

Certain statements in this news release related to the Company constitute “forward-looking information” within the meaning of applicable securities laws and are prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “will”, “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “potential” or “continue”, or the negative thereof or similar variations. Forward-looking information in this news release includes, but is not limited to, statements regarding the Company’s anticipated topline readout for the Phase 3 Voyage study of DT120 ODT in GAD in early 3Q 2026; the Company’s anticipated topline readout for the Phase 3 Panorama study for DT120 ODT in GAD in late 3Q 2026; the Company’s anticipated topline readout for the Phase 3 Emerge study for DT120 ODT in MDD in late 2Q 2026; the Company’s plans to dose the first patient in the Phase 3 Ascend study of DT120 ODT in MDD in 2Q 2026; the Company’s expectations regarding the enrollment for each of the Panorama and Ascend studies; the Company’s expectation to initiate the Haven study of DT120 ODT in PTSD in 2027; the Company’s expectations regarding enrollment and trial design for the Haven study; the Company’s beliefs regarding potential benefits of its product candidates; the Company’s belief that DT120 ODT could be a best-in-class therapy; the Company’s regulatory plans, including the timing of any potential NDA submissions; the Company’s belief in DT120 ODT’s differentiated therapeutic profile and broad applicability across care settings; the potential market opportunity for DT120 ODT; the Company’s commercial strategy; and patient access to and reimbursement of DT120 ODT. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including history of negative cash flows; limited operating history; incurrence of future losses; availability of additional capital; compliance with laws and regulations; legislative and regulatory developments, including decisions by the Drug Enforcement Administration and states to reschedule any of our product candidates, if approved, containing Schedule I controlled substances, before they may be legally marketed in the U.S.; difficulty associated with research and development; risks associated with clinical studies or studies; heightened regulatory scrutiny; early stage product development; clinical study risks; regulatory approval processes; novelty of the psychedelic inspired medicines industry; ability to maintain effective patent rights and other intellectual property protection; as well as those risk factors discussed or referred to herein and the risks, uncertainties and other factors described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 under headings such as “Special Note Regarding Forward-Looking Statements,” and “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other filings and furnishings made by the Company with the securities regulatory authorities in all provinces and territories of Canada, which are available under the Company’s profile on SEDAR+ at www.sedarplus.ca, and with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, changes in expectations or otherwise.

For more information, visit https://definiumtx.com/ and follow Definium Therapeutics on Instagram, LinkedIn, and X.

References:

Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
Liechti, M. E. (2017). Modern clinical research on LSD. Neuropsychopharmacology, 42, 2114–2127. https://doi.org/10.1038/npp.2017.86

View source version on businesswire.com: https://www.businesswire.com/news/home/20260422742468/en/

Investors:

Gitanjali Jain

VP, Head of Investor Relations [email protected]

Media:

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Alternative Medicine Health Mental Health Clinical Trials

MEDIA:

Logo

April 22, 2026 4:40 pm

IBEX Limited to Announce Third Quarter 2026 Financial Results on May 6, 2026

WASHINGTON, April 22, 2026 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced it will report third quarter 2026 financial results after the market close on Wednesday, May 6, 2026. Management will host a conference call and webcast to discuss the Company’s financial results, recent developments, and business outlook at 4:30 p.m. ET.

What:

When:

Time:

Live Call:

Webcast:

IBEX Limited Announces Third Quarter 2026 Financial Results

Wednesday, May 6, 2026

4:30 p.m. ET

About ibex

ibex is a global leader in outsourced business services and AI-powered customer experience solutions, enabling the world’s best brands to deliver truly differentiated experiences for their customers. Leveraging a global team of more than 36,000 human CX experts – powered by the best AI technology, decades of CX innovation, and deep business insights – ibex engineers seamless, end-to-end customer journeys from AI agents to human agents at scale across retail, e-commerce, healthcare, fintech, utilities, technology, logistics, and more. Discover more at ibex.co and connect with us on LinkedIn.

Investor Contact

Tom Colton and Greg Bradbury
Gateway Group, Inc.
949-574-3860
[email protected]

Media Contact

Dan Burris
ibex
[email protected]

April 22, 2026 4:39 pm

Origin Bancorp, Inc. Announces Declaration of Quarterly Cash Dividend

RUSTON, La., April 22, 2026 (GLOBE NEWSWIRE) — Origin Bancorp, Inc. (NYSE: OBK) (“Origin”), the holding company for Origin Bank, today announced that on April 22, 2026, its board of directors declared a quarterly cash dividend of $0.25 per share of its common stock. The cash dividend will be paid on May 29, 2026, to stockholders of record as of the close of business on May 15, 2026.

About Origin Bancorp, Inc.

Origin Bancorp, Inc. is a financial holding company headquartered in Ruston, Louisiana. Origin’s wholly owned bank subsidiary, Origin Bank, was founded in 1912 in Choudrant, Louisiana. Deeply rooted in Origin’s history is a culture committed to providing personalized relationship banking to businesses, municipalities, and personal clients to enrich the lives of the people in the communities it serves. Origin provides a broad range of financial services and currently operates more than 57 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama and the Florida Panhandle. In addition, Origin provides a broad range of insurance agency products and services through its wholly owned insurance agency subsidiary, Forth Insurance, LLC. For more information, visit www.origin.bank and www.forthinsurance.com.

Forward-Looking Statements

When used in filings by Origin Bancorp, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”), in the Company’s press releases or other public or stockholder communications, and in oral statements made with the approval of an authorized executive officer, the words or phrases “anticipates,” “believes,” “estimates,” “expects,” “foresees,” “intends,” “plans,” “projects,” and similar expressions or future or conditional verbs such as “could,” “may,” “might,” “should,” “will,” and “would” or variations of such terms” are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. Factors that might cause such a difference include among other things: the expected payment date of its quarterly cash dividend; changes in economic conditions; other legislative changes generally; changes in policies by regulatory agencies; fluctuations in interest rates; the risks of lending and investing activities, including changes in the level and direction of loan delinquencies and write-offs and changes in estimates of the adequacy of the allowance for loan losses; the Company’s ability to access cost-effective funding; fluctuations in real estate values and both residential and commercial real estate market conditions; demand for loans and deposits in the Company’s market area; competition; and changes in management’s business strategies and other factors set forth in the Company’s filings with the SEC.

The Company does not undertake and specifically declines any obligation – to update or revise any forward-looking statements to reflect events or circumstances that occur after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Contact Information

Investor Relations
Chris Reigelman
318-497-3177
[email protected]

Media Contact
Ryan Kilpatrick
318-232-7472
[email protected]